Dublin, June 06, 2025 (GLOBE NEWSWIRE) -- The "Peripheral Neuropathy Treatment Market 2025-2029" has been added to ResearchAndMarkets.com's offering. Powered by Money.com - Yahoo may earn ...

PR Newswire VICENZA, Italy, October 25, 2016 VICENZA, Italy , October 25, 2016 /PRNewswire/ -- New investments in communication for ASAlaser, which has ...

The team offers innovative medicine and a variety of therapies, including chiropractic, therapeutic exercise and cold laser therapy, to help patients suffering from sciatica, symptoms associated with ...

Key drivers include increased prevalence, new drug approvals, and rising awareness. The report offers comprehensive analysis, segmentation by type, therapy, and region, and a vendor landscape, aiding ...

Key drivers include increased prevalence, new drug approvals, and rising awareness. The report offers comprehensive analysis, segmentation by type, therapy, and region, and a vendor landscape, aiding ...

NEW HAVEN, Conn., June 16, 2025 (GLOBE NEWSWIRE) -- Osmol Therapeutics, a privately held clinical-stage biopharmaceutical company focused on developing preventative treatments for chemotherapy-induced ...

NEW HAVEN, Conn., June 16, 2025 (GLOBE NEWSWIRE) -- Osmol Therapeutics, a privately held clinical-stage biopharmaceutical company focused on developing preventative treatments for chemotherapy ...

Just over a year after its first phase 3 trial of its Engensis gene therapy for painful diabetic peripheral neuropathy (DPN) bombed, Helixmith has started dosing patients in a new study. The South ...

Red light therapy (also known as photobiomodulation or low-level laser therapy) uses specific wavelengths of red and near-infrared light that penetrate the skin and stimulate our cells.

Laser therapy is sometimes called laser ablation. This just means the laser burns away the abnormal cells. You have this treatment as an outpatient. A laser beam is a very strong, hot beam of light.

Methods: 115 patients with chemotherapy-induced peripheral neuropathy (for ≥1 month, with average pain rating of ≥4/10 or ECOG sensory neuropathy ≥1/3) were randomized in this double-blind, ...